• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026

report cover
  • 31 July 2020
  • Pharmaceuticals
  • 130 Pages
  • Report Code: 24LS-16399
  • Formate :   
Download FREE Report Sample Download PDF File

Hereditary Cancer Testing -MARKET ADVISORY SERVICES

Hereditary Cancer Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity?Inc
ARUP Laboratories
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Myriad Genetics
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Strand Life Sciences

Market segment by Type, the product can be split into
RNA Testing
DNA Testing
Market segment by Application, split into
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
1.4 Market by Type
1.4.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RNA Testing
1.4.3 DNA Testing
1.5 Market by Application
1.5.1 Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer
1.5.3 Gastrointestinal Cancer
1.5.4 Prostate Cancer
1.5.5 Respiratory/Lung Cancer
1.5.6 Other Cancers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2015-2026)
2.2 Global Hereditary Cancer Testing Growth Trends by Regions
2.2.1 Hereditary Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hereditary Cancer Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hereditary Cancer Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Market Size
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2015-2020)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hereditary Cancer Testing Market Concentration Ratio
3.2.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2019
3.3 Hereditary Cancer Testing Key Players Head office and Area Served
3.4 Key Players Hereditary Cancer Testing Product Solution and Service
3.5 Date of Enter into Hereditary Cancer Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2015-2020)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hereditary Cancer Testing Market Size by Application (2015-2020)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hereditary Cancer Testing Market Size (2015-2020)
6.2 Hereditary Cancer Testing Key Players in North America (2019-2020)
6.3 North America Hereditary Cancer Testing Market Size by Type (2015-2020)
6.4 North America Hereditary Cancer Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2015-2020)
7.2 Hereditary Cancer Testing Key Players in Europe (2019-2020)
7.3 Europe Hereditary Cancer Testing Market Size by Type (2015-2020)
7.4 Europe Hereditary Cancer Testing Market Size by Application (2015-2020)

8 China
8.1 China Hereditary Cancer Testing Market Size (2015-2020)
8.2 Hereditary Cancer Testing Key Players in China (2019-2020)
8.3 China Hereditary Cancer Testing Market Size by Type (2015-2020)
8.4 China Hereditary Cancer Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hereditary Cancer Testing Market Size (2015-2020)
9.2 Hereditary Cancer Testing Key Players in Japan (2019-2020)
9.3 Japan Hereditary Cancer Testing Market Size by Type (2015-2020)
9.4 Japan Hereditary Cancer Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hereditary Cancer Testing Market Size (2015-2020)
10.2 Hereditary Cancer Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020)

11 India
11.1 India Hereditary Cancer Testing Market Size (2015-2020)
11.2 Hereditary Cancer Testing Key Players in India (2019-2020)
11.3 India Hereditary Cancer Testing Market Size by Type (2015-2020)
11.4 India Hereditary Cancer Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hereditary Cancer Testing Market Size (2015-2020)
12.2 Hereditary Cancer Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hereditary Cancer Testing Market Size by Type (2015-2020)
12.4 Central & South America Hereditary Cancer Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Ambry Genetics (Konica Minota)
13.1.1 Ambry Genetics (Konica Minota) Company Details
13.1.2 Ambry Genetics (Konica Minota) Business Overview
13.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
13.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020))
13.1.5 Ambry Genetics (Konica Minota) Recent Development
13.2 Asper Biogene
13.2.1 Asper Biogene Company Details
13.2.2 Asper Biogene Business Overview
13.2.3 Asper Biogene Hereditary Cancer Testing Introduction
13.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020)
13.2.5 Asper Biogene Recent Development
13.3 Natera
13.3.1 Natera Company Details
13.3.2 Natera Business Overview
13.3.3 Natera Hereditary Cancer Testing Introduction
13.3.4 Natera Revenue in Hereditary Cancer Testing Business (2015-2020)
13.3.5 Natera Recent Development
13.4 Caris Life Sciences
13.4.1 Caris Life Sciences Company Details
13.4.2 Caris Life Sciences Business Overview
13.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
13.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
13.4.5 Caris Life Sciences Recent Development
13.5 BioReference Laboratories (GeneDx)
13.5.1 BioReference Laboratories (GeneDx) Company Details
13.5.2 BioReference Laboratories (GeneDx) Business Overview
13.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
13.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020)
13.5.5 BioReference Laboratories (GeneDx) Recent Development
13.6 LabSolutions
13.6.1 LabSolutions Company Details
13.6.2 LabSolutions Business Overview
13.6.3 LabSolutions Hereditary Cancer Testing Introduction
13.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020)
13.6.5 LabSolutions Recent Development
13.7 Progenity?Inc
13.7.1 Progenity?Inc Company Details
13.7.2 Progenity?Inc Business Overview
13.7.3 Progenity?Inc Hereditary Cancer Testing Introduction
13.7.4 Progenity?Inc Revenue in Hereditary Cancer Testing Business (2015-2020)
13.7.5 Progenity?Inc Recent Development
13.8 ARUP Laboratories
13.8.1 ARUP Laboratories Company Details
13.8.2 ARUP Laboratories Business Overview
13.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
13.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020)
13.8.5 ARUP Laboratories Recent Development
13.9 NeoGenomics
13.9.1 NeoGenomics Company Details
13.9.2 NeoGenomics Business Overview
13.9.3 NeoGenomics Hereditary Cancer Testing Introduction
13.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020)
13.9.5 NeoGenomics Recent Development
13.10 Blueprint Genetics
13.10.1 Blueprint Genetics Company Details
13.10.2 Blueprint Genetics Business Overview
13.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction
13.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
13.10.5 Blueprint Genetics Recent Development
13.11 CellMax Life
10.11.1 CellMax Life Company Details
10.11.2 CellMax Life Business Overview
10.11.3 CellMax Life Hereditary Cancer Testing Introduction
10.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020)
10.11.5 CellMax Life Recent Development
13.12 Fulgent Genetics
10.12.1 Fulgent Genetics Company Details
10.12.2 Fulgent Genetics Business Overview
10.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction
10.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.12.5 Fulgent Genetics Recent Development
13.13 Myriad Genetics
10.13.1 Myriad Genetics Company Details
10.13.2 Myriad Genetics Business Overview
10.13.3 Myriad Genetics Hereditary Cancer Testing Introduction
10.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.13.5 Myriad Genetics Recent Development
13.14 Myogenes
10.14.1 Myogenes Company Details
10.14.2 Myogenes Business Overview
10.14.3 Myogenes Hereditary Cancer Testing Introduction
10.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020)
10.14.5 Myogenes Recent Development
13.15 LabCorp
10.15.1 LabCorp Company Details
10.15.2 LabCorp Business Overview
10.15.3 LabCorp Hereditary Cancer Testing Introduction
10.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020)
10.15.5 LabCorp Recent Development
13.16 Quest Diagnostics
10.16.1 Quest Diagnostics Company Details
10.16.2 Quest Diagnostics Business Overview
10.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction
10.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.16.5 Quest Diagnostics Recent Development
13.17 Pathway Genomics
10.17.1 Pathway Genomics Company Details
10.17.2 Pathway Genomics Business Overview
10.17.3 Pathway Genomics Hereditary Cancer Testing Introduction
10.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.17.5 Pathway Genomics Recent Development
13.18 Strand Life Sciences
10.18.1 Strand Life Sciences Company Details
10.18.2 Strand Life Sciences Business Overview
10.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction
10.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
10.18.5 Strand Life Sciences Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Hereditary Cancer Testing Key Market Segments

Table 2. Key Players Covered: Ranking by Hereditary Cancer Testing Revenue

Table 3. Ranking of Global Top Hereditary Cancer Testing Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of RNA Testing

Table 6. Key Players of DNA Testing

Table 7. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Hereditary Cancer Testing Market Size by Regions (US$ Million): 2020 VS 2026

Table 9. Global Hereditary Cancer Testing Market Size by Regions (2015-2020) (US$ Million)

Table 10. Global Hereditary Cancer Testing Market Share by Regions (2015-2020)

Table 11. Global Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 12. Global Hereditary Cancer Testing Market Share by Regions (2021-2026)

Table 13. Market Top Trends

Table 14. Key Drivers: Impact Analysis

Table 15. Key Challenges

Table 16. Hereditary Cancer Testing Market Growth Strategy

Table 17. Main Points Interviewed from Key Hereditary Cancer Testing Players

Table 18. Global Hereditary Cancer Testing Revenue by Players (2015-2020) (Million US$)

Table 19. Global Hereditary Cancer Testing Market Share by Players (2015-2020)

Table 20. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019)

Table 21. Global Hereditary Cancer Testing by Players Market Concentration Ratio (CR5 and HHI)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Hereditary Cancer Testing Product Solution and Service

Table 24. Date of Enter into Hereditary Cancer Testing Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 27. Global Hereditary Cancer Testing Market Size Share by Type (2015-2020)

Table 28. Global Hereditary Cancer Testing Revenue Market Share by Type (2021-2026)

Table 29. Global Hereditary Cancer Testing Market Size Share by Application (2015-2020)

Table 30. Global Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 31. Global Hereditary Cancer Testing Market Size Share by Application (2021-2026)

Table 32. North America Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 33. North America Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 34. North America Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 35. North America Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 36. North America Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 37. North America Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 38. Europe Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 39. Europe Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 40. Europe Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 41. Europe Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 42. Europe Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 43. Europe Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 44. China Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 45. China Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 46. China Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 47. China Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 48. China Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 49. China Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 50. Japan Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 51. Japan Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 52. Japan Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 53. Japan Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 54. Japan Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 55. Japan Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 56. Southeast Asia Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 57. Southeast Asia Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 58. Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 59. Southeast Asia Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 60. Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 61. Southeast Asia Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 62. India Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 63. India Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 64. India Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 65. India Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 66. India Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 67. India Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 68. Central & South America Key Players Hereditary Cancer Testing Revenue (2019-2020) (Million US$)

Table 69. Central & South America Key Players Hereditary Cancer Testing Market Share (2019-2020)

Table 70. Central & South America Hereditary Cancer Testing Market Size by Type (2015-2020) (Million US$)

Table 71. Central & South America Hereditary Cancer Testing Market Share by Type (2015-2020)

Table 72. Central & South America Hereditary Cancer Testing Market Size by Application (2015-2020) (Million US$)

Table 73. Central & South America Hereditary Cancer Testing Market Share by Application (2015-2020)

Table 74. Ambry Genetics (Konica Minota) Company Details

Table 75. Ambry Genetics (Konica Minota) Business Overview

Table 76. Ambry Genetics (Konica Minota) Product

Table 77. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 78. Ambry Genetics (Konica Minota) Recent Development

Table 79. Asper Biogene Company Details

Table 80. Asper Biogene Business Overview

Table 81. Asper Biogene Product

Table 82. Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 83. Asper Biogene Recent Development

Table 84. Natera Company Details

Table 85. Natera Business Overview

Table 86. Natera Product

Table 87. Natera Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 88. Natera Recent Development

Table 89. Caris Life Sciences Company Details

Table 90. Caris Life Sciences Business Overview

Table 91. Caris Life Sciences Product

Table 92. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 93. Caris Life Sciences Recent Development

Table 94. BioReference Laboratories (GeneDx) Company Details

Table 95. BioReference Laboratories (GeneDx) Business Overview

Table 96. BioReference Laboratories (GeneDx) Product

Table 97. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 98. BioReference Laboratories (GeneDx) Recent Development

Table 99. LabSolutions Company Details

Table 100. LabSolutions Business Overview

Table 101. LabSolutions Product

Table 102. LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 103. LabSolutions Recent Development

Table 104. Progenity?Inc Company Details

Table 105. Progenity?Inc Business Overview

Table 106. Progenity?Inc Product

Table 107. Progenity?Inc Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 108. Progenity?Inc Recent Development

Table 109. ARUP Laboratories Business Overview

Table 110. ARUP Laboratories Product

Table 111. ARUP Laboratories Company Details

Table 112. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 113. ARUP Laboratories Recent Development

Table 114. NeoGenomics Company Details

Table 115. NeoGenomics Business Overview

Table 116. NeoGenomics Product

Table 117. NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 118. NeoGenomics Recent Development

Table 119. Blueprint Genetics Company Details

Table 120. Blueprint Genetics Business Overview

Table 121. Blueprint Genetics Product

Table 122. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 123. Blueprint Genetics Recent Development

Table 124. CellMax Life Company Details

Table 125. CellMax Life Business Overview

Table 126. CellMax Life Product

Table 127. CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 128. CellMax Life Recent Development

Table 129. Fulgent Genetics Company Details

Table 130. Fulgent Genetics Business Overview

Table 131. Fulgent Genetics Product

Table 132. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 133. Fulgent Genetics Recent Development

Table 134. Myriad Genetics Company Details

Table 135. Myriad Genetics Business Overview

Table 136. Myriad Genetics Product

Table 137. Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 138. Myriad Genetics Recent Development

Table 139. Myogenes Company Details

Table 140. Myogenes Business Overview

Table 141. Myogenes Product

Table 142. Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 143. Myogenes Recent Development

Table 144. LabCorp Company Details

Table 145. LabCorp Business Overview

Table 146. LabCorp Product

Table 147. LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 148. LabCorp Recent Development

Table 149. Quest Diagnostics Company Details

Table 150. Quest Diagnostics Business Overview

Table 151. Quest Diagnostics Product

Table 152. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 153. Quest Diagnostics Recent Development

Table 154. Pathway Genomics Company Details

Table 155. Pathway Genomics Business Overview

Table 156. Pathway Genomics Product

Table 157. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 158. Pathway Genomics Recent Development

Table 159. Strand Life Sciences Company Details

Table 160. Strand Life Sciences Business Overview

Table 161. Strand Life Sciences Product

Table 162. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (Million US$)

Table 163. Strand Life Sciences Recent Development

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2020 VS 2026

Figure 2. RNA Testing Features

Figure 3. DNA Testing Features

Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026

Figure 5. Breast Cancer Case Studies

Figure 6. Gastrointestinal Cancer Case Studies

Figure 7. Prostate Cancer Case Studies

Figure 8. Respiratory/Lung Cancer Case Studies

Figure 9. Other Cancers Case Studies

Figure 10. Hereditary Cancer Testing Report Years Considered

Figure 11. Global Hereditary Cancer Testing Market Size YoY Growth 2015-2026 (US$ Million)

Figure 12. Global Hereditary Cancer Testing Market Share by Regions: 2020 VS 2026

Figure 13. Global Hereditary Cancer Testing Market Share by Regions (2021-2026)

Figure 14. Porter's Five Forces Analysis

Figure 15. Global Hereditary Cancer Testing Market Share by Players in 2019

Figure 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019

Figure 17. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2019

Figure 18. North America Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. China Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Japan Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. India Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Central & South America Hereditary Cancer Testing Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Bottom-up and Top-down Approaches for This Report

Figure 26. Data Triangulation

Figure 27. Key Executives Interviewed

Ambry Genetics (Konica Minota)

Asper Biogene

Natera

Caris Life Sciences

BioReference Laboratories (GeneDx)

LabSolutions

Progenity?Inc

ARUP Laboratories

NeoGenomics

Blueprint Genetics

CellMax Life

Fulgent Genetics

Myriad Genetics

Myogenes

LabCorp

Quest Diagnostics

Pathway Genomics

Strand Life Sciences

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase